Report Code: A12670 | Pages: NA | ||
Tables: NA | Charts: NA |
|
mRNA sequencing (mRNA-Seq) is the technique used for examining the transcriptomes of biological processes, disease states, and over a broad range of study designs. mRNA-Sequencing presents a comprehensive picture of the coding transcriptome. mRNA-Sequencing is an accurate & highly sensitive technique of quantifying gene expression, can identify gene fusions, novel and known transcript isoforms, and other features and allele-specific expression. In addition, mRNA-Sequencing can give strand information, which enable more accurate quantification of overlapping transcripts, increases the percentage of alignable reads, and allows the detection of antisense expression.
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the mRNA sequencing market.
Top Impacting Factors
mRNA Sequencing Market Trends
New product launches to flourish the market
Agreement & product launches are key strategies adopted by players in the RNA sequencing market.
On March 12, 2020, Thermo Fisher Scientific signed an agreement with Janssen Research & Development. The agreement aimed to develop a companion diagnostic (CDx) in the field of oncology.
On October 11, 2018, QIAGEN N.V. launched novel RNA-seq library preparation solutions for next-generation sequencing.
Key Benefits of the Report
Questions answered in the mRNA sequencing Report
mRNA Sequencing Market Report Highlights
Aspects | Details |
---|---|
By Sequencing Types |
|
By Technology |
|
By End User |
|
By Region |
|
Key Market Players | Agilent Technologies Inc.,, PerkinElmer Inc., Beijing Genomics Institute, Illumina, Tecan Genomics Inc.,, GE Healthcare, Bio-Rad Laboratories Inc.,, Sigma Aldrich, Eurofins Scientific, Genomatix GmbH, F. Hoffmann-La Roche Ltd,, Thermo Fischer Scientific |
Loading Table Of Content...
Start reading.
This Report and over 71,229+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers